Variant report
Variant | nsv969926 |
---|---|
Chromosome Location | chr5:97319859-97326887 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567916984 | chr5:97319891-97319892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11135548 | chr5:97319897-97319898 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs11951659 | chr5:97319919-97319920 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs114933322 | chr5:97319922-97319923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539172837 | chr5:97319948-97319949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191792252 | chr5:97319989-97319990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79413557 | chr5:97320011-97320012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77269042 | chr5:97320039-97320040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113015226 | chr5:97320112-97320113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571186520 | chr5:97320140-97320141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556050494 | chr5:97320143-97320144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376276826 | chr5:97320153-97320154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11955378 | chr5:97320159-97320160 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs11952416 | chr5:97320168-97320169 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs11949024 | chr5:97320182-97320183 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs545560442 | chr5:97320216-97320217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533608736 | chr5:97320217-97320218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184022238 | chr5:97320307-97320308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11953184 | chr5:97320314-97320315 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs568359486 | chr5:97320389-97320390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529185178 | chr5:97320392-97320393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186978739 | chr5:97320393-97320394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565380731 | chr5:97320408-97320409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116255931 | chr5:97320420-97320421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535664264 | chr5:97320425-97320426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144954701 | chr5:97320446-97320447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149048160 | chr5:97320454-97320455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537669518 | chr5:97320457-97320458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555720999 | chr5:97320465-97320466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549162766 | chr5:97320481-97320482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574368630 | chr5:97320508-97320509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34080298 | chr5:97320522-97320523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545396551 | chr5:97320523-97320524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115662398 | chr5:97320558-97320559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555495872 | chr5:97320581-97320582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62378331 | chr5:97320584-97320585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs386690333 | chr5:97320645-97320646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115948381 | chr5:97320648-97320649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191349947 | chr5:97320674-97320675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143029016 | chr5:97320675-97320676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542898813 | chr5:97320688-97320689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184305703 | chr5:97320711-97320712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543587887 | chr5:97320738-97320739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561758726 | chr5:97320745-97320746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200336553 | chr5:97320759-97320760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376663460 | chr5:97320760-97320761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147770483 | chr5:97320764-97320765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141482012 | chr5:97320812-97320813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557084090 | chr5:97320833-97320834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187044928 | chr5:97320844-97320845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21611746 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:97310600-97321800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:97314800-97321400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:97316200-97321600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr5:97321400-97321800 | Enhancers | Osteobl | bone |
5 | chr5:97321400-97322400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr5:97321400-97322400 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr5:97321400-97322600 | Enhancers | NHDF-Ad | bronchial |
8 | chr5:97321600-97321800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr5:97321600-97321800 | Enhancers | NH-A | brain |
10 | chr5:97321800-97322000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr5:97321800-97322200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr5:97321800-97322200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr5:97321800-97322200 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr5:97321800-97322200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr5:97321800-97322200 | Enhancers | HSMM | muscle |
16 | chr5:97321800-97322200 | Flanking Active TSS | NH-A | brain |
17 | chr5:97321800-97322200 | Flanking Active TSS | Osteobl | bone |
18 | chr5:97322000-97322200 | Enhancers | NHLF | lung |
19 | chr5:97322200-97322400 | Enhancers | NH-A | brain |